Oruka Therapeutics Inc (NASDAQ: ORKA) on Tuesday, plunged -5.76% from the previous trading day, before settling in for the closing price of $30.9. Within the past 52 weeks, ORKA’s price has moved between $5.49 and $32.64.
During the last 5-year period, the sales growth of Healthcare Sector giant was 36.88%. The company achieved an average annual earnings per share of 43.49%. With a float of $42.67 million, this company’s outstanding shares have now reached $48.38 million.
Oruka Therapeutics Inc (ORKA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Oruka Therapeutics Inc is 11.86%, while institutional ownership is 85.36%. The most recent insider transaction that took place on Dec 19 ’25, was worth 214,293. In this transaction Chief Medical Officer of this company sold 7,000 shares at a rate of $30.61, taking the stock ownership to the 1,518 shares. Before that another transaction happened on Dec 19 ’25, when Company’s Officer proposed sale 28,000 for $28.15, making the entire transaction worth $788,200.
Oruka Therapeutics Inc (ORKA) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.49 earnings per share (EPS) for the period topping the consensus outlook (set at -0.98) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.79% during the next five years compared to 36.88% growth over the previous five years of trading.
Oruka Therapeutics Inc (NASDAQ: ORKA) Trading Performance Indicators
Oruka Therapeutics Inc (ORKA) is currently performing well based on its current performance indicators. A quick ratio of 16.94 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.56 in one year’s time.
Technical Analysis of Oruka Therapeutics Inc (ORKA)
Looking closely at Oruka Therapeutics Inc (NASDAQ: ORKA), its last 5-days average volume was 0.48 million, which is a jump from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 56.94%.
During the past 100 days, Oruka Therapeutics Inc’s (ORKA) raw stochastic average was set at 82.22%, which indicates a significant increase from 26.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.07 in the past 14 days, which was higher than the 1.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.94, while its 200-day Moving Average is $17.39. However, in the short run, Oruka Therapeutics Inc’s stock first resistance to watch stands at $30.63. Second resistance stands at $32.14. The third major resistance level sits at $33.38. If the price goes on to break the first support level at $27.88, it is likely to go to the next support level at $26.64. Should the price break the second support level, the third support level stands at $25.13.
Oruka Therapeutics Inc (NASDAQ: ORKA) Key Stats
Market capitalization of the company is 1.41 billion based on 48,409K outstanding shares. Right now, sales total 0 K and income totals -83,720 K. The company made 0 K in profit during its latest quarter, and -30,280 K in sales during its previous quarter.
